– Pivotal trial met its primary endpoint with statistically significant reduction in patients with residual cancer during surgery (p-value = 0.0050) – – Presentation will highlight both previously ...
TORONTO and DALLAS, April 28, 2025 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTCQX: PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical technology company, is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results